Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 3 Breast Neoplasms 3 Recurrence 2 Ovarian Neoplasms 2 Neoplasms 2 Hypersensitivity 2 Neoplasm Metastasis 1 Fanconi Anemia, Complementation Group D1 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Female 1 Brain Neoplasms 1

Interventions

Tamoxifen 2 Paclitaxel 2 pyrotinib 1 pembrolizumab 1 palbociclib 1 iniparib 1 darolutamide 1 Thioctic Acid 1 Pentoxifylline 1 Metformin 1 Letrozole 1 Doxorubicin 1 Cyclophosphamide 1 Capecitabine 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Breast Cancer Female × iniparib × Clear all

NCT01204125 2017-03-22

SOLTI NEOPARP

Sanofi

Phase 2 Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡